Today we cover the Form 483 issued by the US FDA to Dr. Reddy’s oncology formulation manufacturing facility at Duvvada at Visakhapatnam, Andhra Pradesh. ...
Today we cover the Form 483 issued by the US FDA to Cadila Healthcare’s formulations manufacturing plant at Baddi. On another note, the company is due ...
Here is our coverage of the Form 483 issued by the US FDA from the inspection of Divis Laboratories Unit-II located at Visakhapatnam. You can catch all our ...
True to our promise of keeping a tab on the US FDAs inspection of Sun Pharma’s Halol facility, we are happy to get our hands on the Form 483 issued for ...
With the dust yet to settle on the US FDAs inspection of Sun Pharmaceuticals Mohali, Punjab and Halol, Gujarat plants, 2 more companies have reported receiving ...
This is not a recommendation to buy or sell the stock. Analyst and family do own some of the positions listed here. Please assume we are biased. With ...
Drug major Lupin Limited has initiated a recall of 55,348 bottles of Amlodipine Besylate Tablets. This recall has been initiated for the manufacturing ...
At Capital Mind, we bring you today another exclusive article in lines with our earlier production of the exclusive series on Lupin Pharmaceuticals form 483 ...
Welcome to the third and final part of the 3 part exclusive unwrapping of the observations reported from the US FDA’s inspection of Lupin Pharmaceutical’s ...
